| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.58T | 1.53T | 1.44T | 1.36T | 1.15T |
| Gross Profit | 597.15B | 550.76B | 511.45B | 470.39B | 425.90B |
| EBITDA | 261.97B | 209.22B | 232.75B | 226.85B | 197.67B |
| Net Income | 134.68B | 70.27B | 87.12B | 94.06B | 75.72B |
Balance Sheet | |||||
| Total Assets | 1.81T | 1.72T | 1.77T | 1.51T | 1.46T |
| Cash, Cash Equivalents and Short-Term Investments | 106.69B | 164.78B | 171.54B | 132.78B | 151.45B |
| Total Debt | 421.36B | 496.06B | 491.68B | 336.50B | 363.96B |
| Total Liabilities | 968.07B | 907.86B | 890.43B | 688.77B | 717.32B |
| Stockholders Equity | 770.82B | 746.80B | 814.69B | 768.68B | 686.91B |
Cash Flow | |||||
| Free Cash Flow | 142.91B | 121.79B | 102.29B | 49.26B | 71.73B |
| Operating Cash Flow | 239.35B | 209.90B | 168.07B | 117.64B | 145.58B |
| Investing Cash Flow | -84.23B | -77.38B | -132.43B | -30.09B | -61.57B |
| Financing Cash Flow | -225.60B | -137.68B | -6.75B | -111.06B | -123.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥1.11T | 15.42 | 13.07% | 1.82% | 5.72% | 13.87% | |
71 Outperform | ¥4.86T | 23.62 | 9.46% | 1.32% | 3.47% | 99.65% | |
71 Outperform | ¥1.37T | 21.75 | 11.19% | 1.46% | 5.16% | 1.57% | |
71 Outperform | ¥556.16B | 28.74 | 9.28% | 1.30% | 5.86% | -17.47% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | ¥474.92B | 18.06 | 9.86% | 2.58% | 2.00% | 12.21% | |
53 Neutral | ¥785.87B | 19.10 | 9.77% | 2.41% | 1.49% | -14.54% |